CLINICAL PRACTICE GUIDELINE: CYP2D6 GENOTYPING FOR SAFE AND EFFICACIOUS CODEINE THERAPY

被引：0
|
作者：
Madadi, Parvaz [1 ]
Amstutz, Ursula [2 ,3 ,4 ]
Rieder, Michael [5 ,6 ,7 ]
Ito, Shinya [1 ]
Fung, Vincent [8 ,9 ,10 ,11 ]
Hwang, Soomi [3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Turgeon, Jacques [12 ,13 ]
Michaud, Veronique [12 ,13 ]
Koren, Gideon [1 ,5 ,6 ,7 ]
Carleton, Bruce C. [2 ,3 ,4 ]
机构：
[1] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON, Canada
[2] Univ British Columbia, Div Translat Therapeut, Dept Pediat, Vancouver, BC, Canada
[3] BC Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC, Canada
[4] Child & Family Res Inst, Vancouver, BC, Canada
[5] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, Clin Pharmacol, London, ON, Canada
[6] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada
[7] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pediat, London, ON, Canada
[8] Prohlth Clin Res Ctr, Vancouver, BC, Canada
[9] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[10] Univ British Columbia, Fac Med, Dept Family Med, Vancouver, BC, Canada
[11] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada
[12] Ctr Hosp Univ Montreal, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada
[13] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
来源：
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY | 2013年 / 20卷 / 03期
基金：
加拿大健康研究院;
关键词：
Codeine; morphine; pharmacogenetics; CYP2D6; guidelines;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This guideline is intended to provide a basis for informed decision-making regarding genetic testing to identify those individuals who will not benefit from codeine therapy, as well as those who are at an increased risk for codeine-induced toxicity. This guideline addresses the following key questions: 1) Should genetic testing for CYP2D6 be performed in patients prior to the initiation of codeine therapy? 2) How should patients with an indication for codeine therapy be managed based on their genotyping results for CYP2D6?
引用
收藏
页码：E369 / E396
页数：28
相关论文
共 50 条
  • [21] Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practice
    Jurgens, G.
    Jacobsen, C. B.
    Rasmussen, H. B.
    Werge, T.
    Nordentoft, M.
    Andersen, S. E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2012, 125 (03) : 228 - 237
  • [22] Providing Balance in ASCO Clinical Practice Guidelines: CYP2D6 Genotyping and Tamoxifen Efficacy Reply
    Harris, Lyndsay N.
    Ismaila, Nofisat
    McShane, Lisa M.
    Andre, Fabrice
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3946 - +
  • [23] VENLAFAXINE AND CYP2D6 IN CLINICAL PRACTICE: WORK IN PROGRESS
    Zeppegno, P.
    Rolla, R.
    Dalo, V.
    Ressico, F.
    Parafioriti, A.
    Prosperini, P.
    Vidali, M.
    Bellomo, G.
    Torre, E.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [24] VENLAFAXINE AND CYP2D6 IN CLINICAL PRACTICE: AN OBSERVATIONAL STUDY
    Zeppegno, P.
    Rolla, R.
    Dalo', V.
    Ressico, F.
    Parafioriti, A.
    Prosperini, P.
    Bellomo, G.
    Torre, E.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [25] CYP2D6: Detecting New Structures for Clinical Practice
    Henriques, Beatriz Carvalho
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [26] Venlafaxine and CYP2D6 in clinical practice: a case report
    Zeppegno, P.
    Rolla, R.
    Dalo, V.
    Ressico, F.
    Parafioriti, A.
    Prosperini, P.
    Vidali, M.
    Bellomo, G.
    Torre, E.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2011, 17 (04): : 450 - 452
  • [27] An Observational Study of Venlafaxine and CYP2D6 in Clinical Practice
    Rolla, R.
    Gramaglia, Carla
    Dalo, Valentina
    Ressico, Francesca
    Prosperini, Pierluigi
    Vidali, Matteo
    Meola, Silvia
    Pollarolo, Paola
    Bellomo, Giorgio
    Torre, Eugenio
    Zeppegno, Patrizia
    CLINICAL LABORATORY, 2014, 60 (02) : 225 - 231
  • [28] Codeine intoxication associated with ultrarapid CYP2D6 metabolism
    Gasche, Y
    Daali, Y
    Fathi, M
    Chiappe, A
    Cottini, S
    Dayer, P
    Desmeules, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27): : 2827 - 2831
  • [29] Genotyping of CYP2D6 in Parkinson's disease
    Stefanovic, M
    Topic, E
    Ivanisevic, AM
    Relja, M
    Korsic, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (09) : 929 - 934
  • [30] The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
    Ferraldeschi, Roberta
    Newman, William G.
    PHARMACEUTICALS, 2010, 3 (04) : 1122 - 1138
12345